Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS

Clinical trial NCT04708054 · RECRUITING

Trial details

NCT number: NCT04708054
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome

Start date: 2021-10-21
Primary completion: 2027-12-31
Enrollment: 324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.